Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Chinese Journal of School Health ; (12): 419-422, 2023.
Article in Chinese | WPRIM | ID: wpr-965896

ABSTRACT

Objective@#To investigate the longitudinal association of plasma Irisin concentrations with changes in blood pressure (BP) levels among children,and to assess the moderating effect of physical activity (PA) or sedentary behavior (SB) on the relationship between Irisin levels and BP.@*Methods@#Based on a cohort study, a cluster sampling method was used to select 3 651 school aged children from five schools in Guangzhou in 2017 at the baseline survey and follow up in 2019. Both at baseline and during follow up, PA and SB were assessed by validated questionnaires, and BP levels were measured by an electronic sphygmomanometer. A final sample of 521 children were enrolled based on the PA and SB at baseline. Plasma Irisin concentrations were measured by ELISA at baseline. Logistic regression analysis was recruited for exploring the associations of plasma Irisin concentrations with changes in BP. Moderating effects of PA and SB on the relationship between Irisin concentrations and BP were estimated using stratified analysis.@*Results@#Logistic regression analysis indicated that there was no significant association between Irisin concentrations and changes in BP levels among children ( OR =0.98, P >0.05). After stratification for SB, Irisin levels in the low SB subgroup were inversely associated with changes in diastolic blood pressure ( OR=0.87, 95%CI=0.77-0.98, P =0.02). In addition, SB level had a moderating effect on the relationship between Irisin levels and the DBP changes ( P =0.01).@*Conclusion@#Increased Irisin concentration is associated with the decrease of DBP level among low SB children. Furthermore, SB level shows moderating role in the relationship between Irisin concentrations and changes in DBP levels.

2.
Chinese Journal of Postgraduates of Medicine ; (36): 750-753, 2020.
Article in Chinese | WPRIM | ID: wpr-865580

ABSTRACT

Objective:To explore the clinical value of serum sialic acid (SA) for brain glioma diagnosis.Methods:Sixty patients with brain glioma and 60 normal persons (control group) in Deqing People's Hospital from January 2016 to September 2018 were collected, and all the brain glioma patients were divided into low grade group and high grade group according to the pathological grading. The serum SA levels of all the subjects were detected by photocolorimetric method, and the results were analyzed statistically.Results:The positive rate of SA in control group, low grade group and high grade group was 1.7%(1/60), 59.1%(13/22) and 81.6%(31/38), and there was significant difference ( χ2= 6.49, P<0.05). The positive rate in high grade group was higher than that in low grade group and control group, the positive rate in low grade group was higher than that in control group, and there was significant difference ( P<0.05). The level of SA in control group, low grade group and high grade group was 50.9(46.1-58.1), 55.6(48.2-60.9), 64.8(57.9-73.9) mg/L, and there was significant difference ( H= 15.56, P<0.05). The level of SA in high grade group was higher than that in low grade group and control group, the level of SA in low grade group was higher than that in control group, and there was significant difference ( P<0.05). After operation, the level of SA was decreased. At 6 months after operation, the level of SA in low grade group and high grade group was significantly lower than that before operation [low grade group: 50.4 (48.0-59.1) mg/L vs. 55.6(48.2-60.9) mg/L; high grade group: 60.1 (46.0-62.4) mg/L vs. 64.8(57.9-73.9) mg/L] ( P<0.05). At 6 months after operation, the level of SA in high grade group was significantly higher than that in control group [60.1 (46.0-62.4) mg/L vs. 50.9(46.1-58.1) mg/L](P<0.05), but in lower grade group, there was no significant difference [50.4 (48.0-59.1) mg/L vs. 50.9(46.1-58.1) mg/L]( P>0.05). Conclusions:Serum SA can be used in auxiliary diagnosis and prognosis evaluation for brain glioma.

SELECTION OF CITATIONS
SEARCH DETAIL